Hua Liang Selected Research

SETD7 inhibitor PFI-2

6/2021

Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hua Liang Research Topics

Disease

39	Neoplasms (Cancer) 05/2023 - 11/2004
20	Fibrosis (Cirrhosis) 12/2024 - 01/2004
19	Inflammation (Inflammations) 01/2024 - 01/2012
18	Type 2 Diabetes Mellitus (MODY) 04/2024 - 12/2008
16	Infections 01/2023 - 03/2010
12	Insulin Resistance 01/2024 - 12/2008
9	Hypoxia (Hypoxemia) 12/2019 - 12/2014
8	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2014
7	Body Weight (Weight, Body) 01/2024 - 08/2012
7	Bites and Stings (Sting) 12/2022 - 11/2014
7	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2014
7	Lung Neoplasms (Lung Cancer) 12/2019 - 01/2011
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 06/2014
6	Obesity 01/2019 - 09/2009
5	Hepatocellular Carcinoma (Hepatoma) 05/2023 - 01/2014
5	Glioma (Gliomas) 12/2022 - 01/2014
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2012
4	HIV Infections (HIV Infection) 01/2023 - 04/2003
4	Hypertension (High Blood Pressure) 01/2023 - 09/2005
4	Chronic Renal Insufficiency 01/2022 - 06/2021
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2020 - 04/2014
3	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 09/2005
3	Colonic Neoplasms (Colon Cancer) 05/2015 - 10/2006
3	Adenocarcinoma of Lung 07/2013 - 01/2011
3	Carcinoma (Carcinomatosis) 06/2012 - 02/2005
3	Acquired Immunodeficiency Syndrome (AIDS) 03/2010 - 04/2003
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2023 - 03/2023
2	Weight Loss (Weight Reduction) 02/2023 - 05/2016
2	Fatty Liver 01/2023 - 01/2021
2	Albuminuria 01/2023 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2022
2	Ureteral Obstruction 01/2022 - 12/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2014
2	Adenocarcinoma 01/2022 - 07/2013
2	Acute Kidney Injury (Acute Renal Failure) 11/2021 - 05/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2016
2	COVID-19 01/2021 - 12/2020
2	Hyperglycemia 10/2020 - 03/2011
2	Sickle Cell Anemia (Hemoglobin S Disease) 07/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2010
13	Insulin (Novolin)FDA Link 01/2024 - 11/2004
13	Biomarkers (Surrogate Marker)IBA 02/2023 - 04/2003
11	CytokinesIBA 01/2024 - 03/2007
9	Exenatide (Byetta)FDA Link 01/2024 - 11/2014
8	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 11/2004
8	VaccinesIBA 01/2023 - 03/2007
7	AntigensIBA 01/2022 - 04/2011
6	Glucagon-Like Peptide-1 ReceptorIBA 11/2023 - 11/2014
6	LipidsIBA 05/2022 - 08/2012
6	Sirtuin 1IBA 01/2021 - 09/2013
6	Sevoflurane (Ultane)FDA LinkGeneric 12/2016 - 09/2008
5	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 10/2020
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2024 - 06/2021
5	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2003
5	MicroRNAs (MicroRNA)IBA 12/2020 - 04/2014
4	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2013
4	Antiviral Agents (Antivirals)IBA 12/2020 - 03/2010
4	Messenger RNA (mRNA)IBA 01/2019 - 11/2004
4	ChemokinesIBA 10/2018 - 07/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2013
4	Anesthetics (Anesthetic Agents)IBA 12/2016 - 01/2011
3	Hypoglycemic Agents (Hypoglycemics)IBA 04/2024 - 12/2019
3	Interleukin-18 (Interleukin 18)IBA 05/2023 - 06/2016
3	Acetates (Acetic Acid Esters)FDA Link 01/2023 - 01/2016
3	InterferonsIBA 01/2023 - 01/2022
3	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2023 - 01/2016
3	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2023 - 01/2016
3	SaltsIBA 01/2023 - 01/2016
3	Interferon Regulatory FactorsIBA 01/2023 - 11/2021
3	PolymersIBA 12/2022 - 03/2015
3	Interferon Type IIBA 01/2022 - 11/2014
3	Extracellular Matrix ProteinsIBA 01/2022 - 12/2017
3	SurvivinIBA 01/2022 - 12/2015
3	CholesterolIBA 01/2021 - 09/2005
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2020 - 06/2012
3	NF-kappa B (NF-kB)IBA 01/2020 - 12/2008
3	Indicators and Reagents (Reagents)IBA 01/2020 - 11/2014
3	LigandsIBA 01/2020 - 05/2009
3	Cisplatin (Platino)FDA LinkGeneric 05/2016 - 07/2013
3	SolutionsIBA 03/2016 - 10/2006
3	Starch (Cornstarch)IBA 05/2015 - 10/2006
3	Triglycerides (Triacylglycerol)IBA 03/2010 - 09/2005
2	Mitochondrial DNA (mtDNA)IBA 02/2023 - 01/2017
2	Acarbose FDA LinkGeneric 02/2023 - 01/2023
2	Lysine (L-Lysine)FDA Link 01/2023 - 06/2021
2	Phospholipases (Phospholipase)IBA 01/2023 - 05/2022
2	Adenosine Monophosphate (AMP)IBA 12/2022 - 02/2011
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2022
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 11/2014
2	CollagenIBA 01/2022 - 01/2004
2	CalciumIBA 01/2021 - 01/2010
2	Sterol Regulatory Element Binding Protein 1IBA 12/2020 - 03/2014
2	AlbuminsIBA 10/2020 - 09/2005
2	AntibodiesIBA 07/2020 - 01/2020

Therapy/Procedure

28	Therapeutics 01/2023 - 06/2005
10	Radiotherapy 12/2022 - 02/2010
6	Drug Therapy (Chemotherapy) 04/2024 - 10/2012
3	Immunotherapy 12/2021 - 07/2016
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 12/2020
2	Transplantation 01/2022 - 01/2022